The collaboration will make lower‑cost biosimilar alternatives to Humira and Stelara available to commercial members.

This drug has boxed warnings. These are the most serious warnings from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous.

The price you pay for Amjevita may depend on factors such as the form you’re prescribed and whether you have health insurance. Financial assistance may be available to help you with the cost of ...

The first biosimilars referencing Humira became available in 2023. That year, 10 FDA-approved adalimumab are now on the ...

Adalimumab, sold under the brand name Humira, enjoyed a long run as one of the world's best-selling medicines. But its 20-year, competition-free period has ended, and despite its best efforts to delay ...

MedImpact Holdings, Inc. today announced the launch of an unbranded biosimilar to Humira(R) (adalimumab) priced at 95% below the brand-name cost. MedImpact is offering this biosimilar (Adalumymab-ryvk ...

Rebates aren’t disappearing, but PSG's 2026 survey suggests payers increasingly favor lower net costs, biosimilars and price ...